{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T14:15:01Z","timestamp":1784729701030,"version":"3.55.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82274540"],"award-info":[{"award-number":["82274540"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Induced membrane technique (IMT), a novel approach for reconstructing critical-size bone defect, encounters the challenge of lengthy mineralization time after bone grafting. Total flavonoids of\n                      <jats:italic>Rhizoma drynariae<\/jats:italic>\n                      (TFRD), the extracts from dried rhizome of Drynaria roosii Nakaike, is widely used in the treatment of orthopedic diseases.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>This study primarily investigates the impact of TFRD on the NRF2-mediated anti-ferroptosis effect in osteoblasts within the IMT bone grafting area.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>An IMT model was established in the right femur of rats. After 4 and 8\u00a0weeks of treatment with TFRD and DMF (an NRF2 activator) respectively, bone defect repair and ferroptosis-related indicators were evaluated. In vitro, an Erastin-induced ferroptosis model of osteoblasts was constructed to analyze the mineralization capacity of osteoblasts, ferroptosis-related indicators, and factors related to the NRF2\/ARE pathway under TFRD and DMF treatment. Additionally, the components of TFRD and TFRD-containing serum were analyzed using UHPLC-Q-Orbitrap HRMS. Finally, the main compounds in TFRD that bind to the NRF2 protein were studied through molecular docking, molecular dynamics simulation (MDS), and CETSA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In vivo results demonstrated that excessive iron accumulation occurred in the IMT bone grafting area, accompanied by elevated levels of lipid peroxidation products (MDA and 4-HNE) and decreased levels of antioxidants (GSH), suggesting the presence of ferroptosis during the bone graft mineralization process in IMT. Treatment with TFRD and DMF reduced iron accumulation and the production of MDA and 4-HNE, accelerated bone defect healing, and enhanced expression of osteogenesis-related factors and NRF2\/ARE pathway factors. In vitro experiments revealed that Erastin induced ferroptosis in osteoblasts, diminishing cell viability and mineralization capacity. Treatment with TFRD and DMF alleviated mitochondrial damage, reduced production of ROS, MDA and 4-HNE, increased the expression of osteogenesis-related factors, upregulated the NRF2\/ARE pathway, and enhanced cell viability and mineralization. Meanwhile, five active components in TFRD and TFRD-containing serum were identified using UHPLC-Q-Orbitrap HRMS. Molecular docking, MDS and CETSA results indicated that the main compounds in TFRD-containing serum could directly bind to the NRF2 protein in osteoblasts and maintain its stability.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The NRF2-mediated anti-ferroptosis effect in osteoblasts positively regulated the mineralization of osteoblasts. The main components of TFRD targeted NRF2 in osteoblasts within the IMT bone grafting area, maintained its stability, promoted the expression of downstream antioxidant response elements (ARE), enhanced the anti-ferroptosis role of osteoblasts, thereby accelerating the repair of bone defects.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13020-026-01347-7","type":"journal-article","created":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T07:19:19Z","timestamp":1773386359000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Total flavonoids of Rhizoma drynariae targets NRF2-mediated anti-ferroptosis in osteoblasts to promote induced membrane osteogenesis"],"prefix":"10.1186","volume":"21","author":[{"given":"Shuyuan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanpeng","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qunbin","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qishi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,13]]},"reference":[{"issue":"9","key":"1347_CR1","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1097\/00007632-199505000-00012","volume":"20","author":"JC Banwart","year":"1995","unstructured":"Banwart JC, Asher MA, Hassanein RS. Iliac crest bone graft harvest donor site morbidity: a statistical evaluation. Spine (Phila Pa 1976). 1995;20(9):1055\u201360. https:\/\/doi.org\/10.1097\/00007632-199505000-00012.","journal-title":"Spine (Phila Pa 1976)"},{"key":"1347_CR2","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1097\/00003086-200202000-00006","volume":"395","author":"RW Bucholz","year":"2002","unstructured":"Bucholz RW. Nonallograft osteoconductive bone graft substitutes. Clin Orthop Relat Res. 2002;395:44\u201352. https:\/\/doi.org\/10.1097\/00003086-200202000-00006.","journal-title":"Clin Orthop Relat Res"},{"issue":"3","key":"1347_CR3","first-page":"346","volume":"45","author":"AC Masquelet","year":"2000","unstructured":"Masquelet AC, Fitoussi F, Begue T, Muller GP. Reconstruction of the long bones by the induced membrane and spongy autograft. Ann Chir Plast Esthet. 2000;45(3):346\u201353.","journal-title":"Ann Chir Plast Esthet"},{"issue":"1","key":"1347_CR4","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ocl.2009.07.011","volume":"41","author":"AC Masquelet","year":"2010","unstructured":"Masquelet AC, B\u00e9gu\u00e9 T. The concept of induced membrane for reconstruction of long bone defects. Orthop Clin North Am. 2010;41(1):27\u201337. https:\/\/doi.org\/10.1016\/j.ocl.2009.07.011.","journal-title":"Orthop Clin North Am"},{"issue":"2","key":"1347_CR5","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.injury.2019.12.032","volume":"51","author":"M Mi","year":"2020","unstructured":"Mi M, Papakostidis C, Wu X, Giannoudis PV. Mixed results with the Masquelet technique: a fact or a myth? Injury. 2020;51(2):132\u20135. https:\/\/doi.org\/10.1016\/j.injury.2019.12.032.","journal-title":"Injury"},{"issue":"6","key":"1347_CR6","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.tcb.2020.02.009","volume":"30","author":"BR Stockwell","year":"2020","unstructured":"Stockwell BR, Jiang X, Gu W. Emerging mechanisms and disease relevance of ferroptosis. Trends Cell Biol. 2020;30(6):478\u201390. https:\/\/doi.org\/10.1016\/j.tcb.2020.02.009.","journal-title":"Trends Cell Biol"},{"issue":"38","key":"1347_CR7","doi-asserted-by":"publisher","first-page":"19319","DOI":"10.1073\/pnas.1905132116","volume":"116","author":"WS Yang","year":"2019","unstructured":"Yang WS, Kim SH, Gaschler MM, Patel M, Shchepinov MS, Stockwell BR. Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis. Proc Natl Acad Sci U S A. 2019;116(38):19319\u201328. https:\/\/doi.org\/10.1073\/pnas.1905132116.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"1347_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/metabo13040578","volume":"13","author":"A Akhmetshina","year":"2023","unstructured":"Akhmetshina A, Kratky D, Rendina-Ruedy E. Influence of cholesterol on the regulation of osteoblast function. Metabolites. 2023;13(4):578. https:\/\/doi.org\/10.3390\/metabo13040578.","journal-title":"Metabolites"},{"issue":"10","key":"1347_CR9","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1359\/jbmr.070518","volume":"22","author":"RL Jilka","year":"2007","unstructured":"Jilka RL, Weinstein RS, Parfitt AM, Manolagas SC. Quantifying osteoblast and osteocyte apoptosis: challenges and rewards. J Bone Miner Res. 2007;22(10):1492\u2013501. https:\/\/doi.org\/10.1359\/jbmr.070518.","journal-title":"J Bone Miner Res"},{"issue":"12","key":"1347_CR10","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202500415R","volume":"39","author":"C Li","year":"2025","unstructured":"Li C, Gong H, Zhang Y, Shi P, Liu S, Zhang Q. Ferroptosis as an emerging target in diabetic osteoporosis. FASEB J. 2025;39(12):e70769. https:\/\/doi.org\/10.1096\/fj.202500415R.","journal-title":"FASEB J"},{"key":"1347_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2025.123532","volume":"324","author":"C Ye","year":"2026","unstructured":"Ye C, Xu J, Shi L, Zong C, Ji W, Lu Y, et al. Injectable natural Tremella-derived hydrogel for reversing ferroptosis-mediated osteoporotic microenvironment imbalance and promoting osteoregeneration. Biomaterials. 2026;324:123532. https:\/\/doi.org\/10.1016\/j.biomaterials.2025.123532.","journal-title":"Biomaterials"},{"issue":"3","key":"1347_CR12","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.13779","volume":"58","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Li J, Liu J, Gao Y, Li K, Zhao X, et al. Ferroptosis in osteoarthritis: towards novel therapeutic strategy. Cell Prolif. 2025;58(3):e13779. https:\/\/doi.org\/10.1111\/cpr.13779.","journal-title":"Cell Prolif"},{"key":"1347_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103464","volume":"79","author":"AI Rojo","year":"2025","unstructured":"Rojo AI, Buttari B, Cadenas S, Carlos AR, Cuadrado A, Falc\u00e3o AS, et al. Model organisms for investigating the functional involvement of NRF2 in non-communicable diseases. Redox Biol. 2025;79:103464. https:\/\/doi.org\/10.1016\/j.redox.2024.103464.","journal-title":"Redox Biol"},{"key":"1347_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1587231","volume":"16","author":"Y Yang","year":"2025","unstructured":"Yang Y, Zou H. Research progress on Nrf2 intervention in the treatment of diabetic retinopathy. Front Endocrinol (Lausanne). 2025;16:1587231. https:\/\/doi.org\/10.3389\/fendo.2025.1587231.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"11","key":"1347_CR15","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1038\/s41401-024-01336-2","volume":"45","author":"X Jiang","year":"2024","unstructured":"Jiang X, Yu M, Wang WK, Zhu LY, Wang X, Jin HC, et al. The regulation and function of Nrf2 signaling in ferroptosis-activated cancer therapy. Acta Pharmacol Sin. 2024;45(11):2229\u201340. https:\/\/doi.org\/10.1038\/s41401-024-01336-2.","journal-title":"Acta Pharmacol Sin"},{"issue":"12","key":"1347_CR16","doi-asserted-by":"publisher","first-page":"16479","DOI":"10.1007\/s00210-025-04324-3","volume":"398","author":"AAM Abdelgawwad El-Sehrawy","year":"2025","unstructured":"Abdelgawwad El-Sehrawy AAM, Al-Dulaimi AA, Alkhathami AG, Renuka Jyothi S, Panigrahi R, Pargaien A, et al. NRF2 as a ferroptosis gatekeeper in colorectal cancer: implications for therapy. Naunyn Schmiedebergs Arch Pharmacol. 2025;398(12):16479\u2013506. https:\/\/doi.org\/10.1007\/s00210-025-04324-3.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"1347_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2022.115565","volume":"297","author":"CH Peng","year":"2022","unstructured":"Peng CH, Lin WY, Li CY, Dharini KK, Chang CY, Hong JT, et al. Gu sui bu (Drynaria fortunei J. Sm.) antagonizes glucocorticoid-induced mineralization reduction in zebrafish larvae by modulating the activity of osteoblasts and osteoclasts. J Ethnopharmacol. 2022;297:115565. https:\/\/doi.org\/10.1016\/j.jep.2022.115565.","journal-title":"J Ethnopharmacol"},{"key":"1347_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2024.118141","volume":"329","author":"X Wang","year":"2024","unstructured":"Wang X, Tang P, Yang K, Guo S, Tang Y, Zhang H, et al. Regulation of bone homeostasis by traditional Chinese medicine active scaffolds and enhancement for the osteoporosis bone regeneration. J Ethnopharmacol. 2024;329:118141. https:\/\/doi.org\/10.1016\/j.jep.2024.118141.","journal-title":"J Ethnopharmacol"},{"key":"1347_CR19","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.2147\/DDDT.S139804","volume":"11","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Jiang J, Shen H, Chai Y, Wei X, Xie Y. Total flavonoids from Rhizoma Drynariae (Gusuibu) for treating osteoporotic fractures: implication in clinical practice. Drug Des Devel Ther. 2017;11:1881\u201390. https:\/\/doi.org\/10.2147\/DDDT.S139804.","journal-title":"Drug Des Devel Ther"},{"issue":"1","key":"1347_CR20","doi-asserted-by":"publisher","first-page":"13","DOI":"10.2174\/1573409918666221006122426","volume":"19","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Weng Q, Hu T, Shen X, Han J. Prediction of Rhizoma Drynariae targets in the treatment of osteonecrosis of the femoral head based on network pharmacology and experimental verification. Curr Comput Aided Drug Des. 2023;19(1):13\u201323. https:\/\/doi.org\/10.2174\/1573409918666221006122426.","journal-title":"Curr Comput Aided Drug Des"},{"key":"1347_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.675470","volume":"12","author":"S Li","year":"2021","unstructured":"Li S, Zhou HL, Hu C, Yang JB, Ye JF, Zhou YX, et al. Total flavonoids of Rhizoma Drynariae promotes differentiation of osteoblasts and growth of bone graft in induced membrane partly by activating Wnt\/\u03b2-catenin signaling pathway. Front Pharmacol. 2021;12:675470. https:\/\/doi.org\/10.3389\/fphar.2021.675470.","journal-title":"Front Pharmacol"},{"issue":"3","key":"1347_CR22","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1080\/21551197.2012.698220","volume":"31","author":"CM Weaver","year":"2012","unstructured":"Weaver CM, Alekel DL, Ward WE, Ronis MJ. Flavonoid intake and bone health. J Nutr Gerontol Geriatr. 2012;31(3):239\u201353. https:\/\/doi.org\/10.1080\/21551197.2012.698220.","journal-title":"J Nutr Gerontol Geriatr"},{"issue":"2","key":"1347_CR23","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1002\/term.192","volume":"11","author":"R Gouron","year":"2017","unstructured":"Gouron R, Petit L, Boudot C, Six I, Brazier M, Kamel S, et al. Osteoclasts and their precursors are present in the induced-membrane during bone reconstruction using the Masquelet technique. J Tissue Eng Regen Med. 2017;11(2):382\u20139. https:\/\/doi.org\/10.1002\/term.192.","journal-title":"J Tissue Eng Regen Med"},{"issue":"3","key":"1347_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/life15030414","volume":"15","author":"C Fischer","year":"2025","unstructured":"Fischer C, Langwald S, Klauke F, Kobbe P, Mendel T, H\u00fcckst\u00e4dt M. Introducing the pearl-string technique: a new concept in the treatment of large bone defects. Life (Basel). 2025;15(3):414. https:\/\/doi.org\/10.3390\/life15030414.","journal-title":"Life (Basel)"},{"issue":"7","key":"1347_CR25","doi-asserted-by":"publisher","DOI":"10.5312\/wjo.v16.i7.107337","volume":"16","author":"AL Shastov","year":"2025","unstructured":"Shastov AL, Kolchin SN, Malkova TA. Effectiveness of the induced membrane technique in aseptic and infected long-bone defect management: are there any differences? World J Orthop. 2025;16(7):107337. https:\/\/doi.org\/10.5312\/wjo.v16.i7.107337.","journal-title":"World J Orthop"},{"key":"1347_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2024.117384","volume":"192","author":"S Li","year":"2025","unstructured":"Li S, Li S, Yang D, Zhang J, Wang S, Zeng Z, et al. NRF2-mediated osteoblast anti-ferroptosis effect promotes induced membrane osteogenesis. Bone. 2025;192:117384. https:\/\/doi.org\/10.1016\/j.bone.2024.117384.","journal-title":"Bone"},{"key":"1347_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2022.153995","volume":"99","author":"S Li","year":"2022","unstructured":"Li S, Li Y, Jiang Z, Hu C, Gao Y, Zhou Q. Efficacy of total flavonoids of Rhizoma drynariae on the blood vessels and the bone graft in the induced membrane. Phytomedicine. 2022;99:153995. https:\/\/doi.org\/10.1016\/j.phymed.2022.153995.","journal-title":"Phytomedicine"},{"key":"1347_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115748","volume":"168","author":"J Che","year":"2023","unstructured":"Che J, Yang X, Jin Z, Xu C. Nrf2: a promising therapeutic target in bone-related diseases. Biomed Pharmacother. 2023;168:115748. https:\/\/doi.org\/10.1016\/j.biopha.2023.115748.","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"1347_CR29","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s00223-019-00576-3","volume":"105","author":"Y Kubo","year":"2019","unstructured":"Kubo Y, Wruck CJ, Fragoulis A, Drescher W, Pape HC, Lichte P, et al. Role of Nrf2 in fracture healing: clinical aspects of oxidative stress. Calcif Tissue Int. 2019;105(4):341\u201352. https:\/\/doi.org\/10.1007\/s00223-019-00576-3.","journal-title":"Calcif Tissue Int"},{"issue":"1","key":"1347_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s12891-022-05942-1","volume":"23","author":"Y Kubo","year":"2022","unstructured":"Kubo Y, Gonzalez JAH, Beckmann R, Weiler M, Pahlavani H, Saldivar MC, et al. Nuclear factor erythroid 2-related factor 2 (Nrf2) deficiency causes age-dependent progression of female osteoporosis. BMC Musculoskelet Disord. 2022;23(1):1015. https:\/\/doi.org\/10.1186\/s12891-022-05942-1.","journal-title":"BMC Musculoskelet Disord"},{"key":"1347_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2020.00116","volume":"13","author":"MA Hannan","year":"2020","unstructured":"Hannan MA, Dash R, Sohag AAM, Haque MN, Moon IS. Neuroprotection against oxidative stress: phytochemicals targeting TrkB signaling and the Nrf2-ARE antioxidant system. Front Mol Neurosci. 2020;13:116. https:\/\/doi.org\/10.3389\/fnmol.2020.00116.","journal-title":"Front Mol Neurosci"},{"issue":"1","key":"1347_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-025-02491-z","volume":"11","author":"X Yang","year":"2025","unstructured":"Yang X, Liu Y, Cao J, Wu C, Tang L, Bian W, et al. Targeting epigenetic and post-translational modifications of NRF2: key regulatory factors in disease treatment. Cell Death Discov. 2025;11(1):189. https:\/\/doi.org\/10.1038\/s41420-025-02491-z.","journal-title":"Cell Death Discov"},{"issue":"7","key":"1347_CR33","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.19540\/j.cnki.cjcmm.20170224.010","volume":"42","author":"FX Ma","year":"2017","unstructured":"Ma FX, Xue PF, Wang YY, Wang YN, Xue SY. Research progress of serum pharmacochemistry of traditional Chinese medicine. Zhongguo Zhong Yao Za Zhi. 2017;42(7):1265\u201370. https:\/\/doi.org\/10.19540\/j.cnki.cjcmm.20170224.010.","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"issue":"7","key":"1347_CR34","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/S1875-5364(22)60206-1","volume":"20","author":"YP Tang","year":"2022","unstructured":"Tang YP, Xu DQ, Yue SJ, Chen YY, Fu RJ, Bai X. Modern research thoughts and methods on bio-active components of TCM formulae. Chin J Nat Med. 2022;20(7):481\u201393. https:\/\/doi.org\/10.1016\/S1875-5364(22)60206-1.","journal-title":"Chin J Nat Med"}],"container-title":["Chinese Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-026-01347-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13020-026-01347-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-026-01347-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T07:19:20Z","timestamp":1773386360000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13020-026-01347-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,13]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1347"],"URL":"https:\/\/doi.org\/10.1186\/s13020-026-01347-7","relation":{},"ISSN":["1749-8546"],"issn-type":[{"value":"1749-8546","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,13]]},"assertion":[{"value":"31 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"83"}}